These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2157083)

  • 1. Karyometric and DNA content analyses of cancer cells in stage III breast cancer with reference to prognosis.
    Tamura G; Masuda T; Satoh T; Satodate R; Ishida M; Saitoh K
    Jpn J Clin Oncol; 1990 Mar; 20(1):78-82. PubMed ID: 2157083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nuclear morphometry of cancer cells in stage III breast cancer with special reference to prognosis].
    Tamura G; Masuda T; Satodate R; Ishida M; Saitoh K
    Gan No Rinsho; 1988 Jul; 34(8):977-80. PubMed ID: 3404660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G; Maesawa C; Mikawa S; Satodate R
    Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
    Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis.
    Toropainen EM; Lipponen PK; Syrjanen KJ
    Anticancer Res; 1995; 15(6B):2669-74. PubMed ID: 8669844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].
    Zubrikhina GN; Ermilova VD; Kuz'mina ZV; Bassalyk LS
    Arkh Patol; 1989; 51(3):10-6. PubMed ID: 2545183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of nuclear DNA content in breast cancer].
    Nishi T; Okajima K; Taguchi T; Ryo T; Mizutani H; Kawashima Y; Sekimoto T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):569-77. PubMed ID: 2351850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
    Crissman JD; Visscher DW; Kubus J
    Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
    Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
    Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers.
    Olive PL; Durand RE; Le Riche J; Olivotto IA; Jackson SM
    Cancer Res; 1993 Feb; 53(4):733-6. PubMed ID: 8381327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of relapse in patients with breast cancer by DNA cytometry.
    Machado-Santelli GM; Mori L; Pereira CA
    Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy in screening-detected non-palpable mammary carcinomas.
    von Rosen A; Frisell J; Azavedo E; Auer G
    Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of morphological parameters for infiltrating ductal breast cancer prognosis.
    Mariuzzi GM; Mambelli V; Criante P; Sisti S
    Pathol Res Pract; 1989 Nov; 185(5):698-700. PubMed ID: 2560543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the cellular centrosome in fine-needle aspirations of the breast.
    Guo HQ; Gao M; Ma J; Xiao T; Zhao LL; Gao Y; Pan QJ
    Breast Cancer Res; 2007; 9(4):R48. PubMed ID: 17662154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
    Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
    Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.